Chemical Structure : CU-CPT22
CAS No.: 1416324-85-0
货号: PC-38135Not For Human Use, Lab Use Only.
CU-CPT22 is a specific small-molecule inhibitor of the TLR1/TLR2 complex with IC50 of 0.58 uM (NO production in RAW 264.7 cells).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥980 | In stock | |
10 mg | ¥1480 | In stock | |
25 mg | ¥2580 | In stock | |
50 mg | ¥4280 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CU-CPT22 is a specific small-molecule inhibitor of the TLR1/TLR2 complex with IC50 of 0.58 uM (NO production in RAW 264.7 cells).
CU-CPT22 preferentially inhibits TLR2/1 signaling, without affecting a panel of homologous TLRs (TLR2/6, TLR3, TLR4, and TLR7).
CU-CPT22 competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with high inhibitory activity and specificity.
CU-CPT22 demonstrated minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4).
CU-CPT22 also inhibits the downstream signaling transduction in cellular assays, inhibits TNF-α (60%) and IL-1β (95%) at 8 uM in the Pam3CSK4-activated RAW 264.7 cells.
CU-CPT22 reduced the nuclear translocation of NF-κB and secretion of TNF-α from cultured primary mouse microglia.
CU-CPT22 also inhibits the downstream signaling transduction in cellular assays, inhibits TNF-α (60%) and IL-1β (95%) at 8 uM in the Pam3CSK4-activated RAW 264.7 cells.
分子量 | 362.378 | |
分子式 | C19H22O7 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Hexyl 3,4,6-trihydroxy-2-methoxy-5-oxo-5H-benzo[7]annulene-8-carboxylate |
1. Cheng K, et al. Angew Chem Int Ed Engl. 2012 Dec 3;51(49):12246-9.
2. Daniele SG, et al. Sci Signal. 2015 May 12;8(376):ra45.
3. Bock S, et al. Pharmacol Res. 2016 Mar;105:44-53.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright